ISIN Code | ES0105618005 | Sector | Consumer services | |
Ticker | Subsector | Pharmacy Products and Biotechnology | ||
Speaker | Albert Jane (CEO-COO-Cofounder) | |||
Private Meetings | jordi rovira (CFO) Albert Jane (CEO-COO-Cofounder) |
|||
Profile | Vytrus Biotech's goal is to be a benchmark in the dermo-cosmetic ingredients sector in innovation and sustainability through our biotechnological platforms of plant stem cell cultures. We promote skin health to improve people's appearance and well-being. At Vytrus Biotech we develop, produce and market worldwide high value-added active ingredients in the dermo-cosmetic market. Plant stem cell technology has enormous potential not only in dermo-cosmetics but also in other sectors such as veterinary medicine, functional food and pharmaceuticals. For the first time, technology and nature can be combined in a single product. Vytrus Biotech's biotechnology gives it a competitive advantage over traditional plant extracts. We obtain highly effective, sustainable and safe products, generating savings of more than 99% in natural resources and contributing to the preservation of the planet's biodiversity. |
|||
Web | https://www.vytrus.com/es/ |